1. Home
  2. M vs TGTX Comparison

M vs TGTX Comparison

Compare M & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • M
  • TGTX
  • Stock Information
  • Founded
  • M 1830
  • TGTX 1993
  • Country
  • M United States
  • TGTX United States
  • Employees
  • M N/A
  • TGTX N/A
  • Industry
  • M Department/Specialty Retail Stores
  • TGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • M Consumer Discretionary
  • TGTX Health Care
  • Exchange
  • M Nasdaq
  • TGTX Nasdaq
  • Market Cap
  • M 4.8B
  • TGTX 5.5B
  • IPO Year
  • M N/A
  • TGTX 1995
  • Fundamental
  • Price
  • M $19.46
  • TGTX $33.87
  • Analyst Decision
  • M Hold
  • TGTX Strong Buy
  • Analyst Count
  • M 10
  • TGTX 5
  • Target Price
  • M $15.72
  • TGTX $48.20
  • AVG Volume (30 Days)
  • M 6.9M
  • TGTX 1.8M
  • Earning Date
  • M 11-25-2025
  • TGTX 11-03-2025
  • Dividend Yield
  • M 3.76%
  • TGTX N/A
  • EPS Growth
  • M 304.55
  • TGTX N/A
  • EPS
  • M 1.77
  • TGTX 2.78
  • Revenue
  • M $22,701,000,000.00
  • TGTX $531,898,000.00
  • Revenue This Year
  • M N/A
  • TGTX $82.31
  • Revenue Next Year
  • M N/A
  • TGTX $49.05
  • P/E Ratio
  • M $10.99
  • TGTX $12.18
  • Revenue Growth
  • M N/A
  • TGTX 100.88
  • 52 Week Low
  • M $9.76
  • TGTX $22.92
  • 52 Week High
  • M $19.99
  • TGTX $46.48
  • Technical
  • Relative Strength Index (RSI)
  • M 64.78
  • TGTX 49.40
  • Support Level
  • M $19.24
  • TGTX $31.07
  • Resistance Level
  • M $19.99
  • TGTX $36.65
  • Average True Range (ATR)
  • M 0.51
  • TGTX 1.70
  • MACD
  • M 0.06
  • TGTX -0.18
  • Stochastic Oscillator
  • M 79.21
  • TGTX 50.09

About M Macy's Inc

Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Share on Social Networks: